4 free views remaining today
developmental and epileptic encephalopathy 79
Description
Developmental and Epileptic Encephalopathy (DEE): A Rare and Severe Form of Epilepsy
Developmental and epileptic encephalopathy (DEE) is a rare and severe form of epilepsy that affects individuals, typically beginning in infancy or childhood. This condition is characterized by frequent seizures of multiple types, intellectual disability, and significant developmental delay, regression, or plateau [1][2].
Key Features:
- Frequent seizures of multiple different types
- Intellectual disability and significant developmental delay, regression, or plateau
- Associated with genetic variants in many cases
- Onset typically during early childhood
Causes and Contributing Factors:
DEEs are often associated with genetic variants, which can contribute to the development of both epilepsy and intellectual disability [3][4]. In some cases, other factors such as environmental influences or infections may also play a role.
Symptoms and Diagnosis:
The symptoms of DEE can vary widely depending on the individual case. However, common features include:
- Frequent seizures that can be difficult to control with medication
- Intellectual disability and significant developmental delay, regression, or plateau
- Behavioral problems and emotional difficulties
Diagnosis is typically made through a combination of clinical evaluation, medical history, and diagnostic tests such as EEG and imaging studies.
Treatment and Management:
While there is no cure for DEE, various treatment options are available to manage the symptoms and improve quality of life. These may include:
- Medications to control seizures
- Behavioral therapies to address developmental delays and intellectual disability
- Supportive care to manage behavioral problems and emotional difficulties
It's essential to work with a healthcare team experienced in managing rare and complex conditions like DEE.
References:
[1] Developmental and Epileptic Encephalopathies (DEEs) are a group of rare and severe epilepsies. [Source 1]
[2] Developmental and epileptic encephalopathies, the most severe group of epilepsies, are characterized by seizures and frequent epileptiform activity associated with developmental slowing or regression. [Source 2]
[3] Genetic variants are frequently responsible for epileptic encephalopathies, conditions in which an increased susceptibility to epileptic seizures is associated with cognitive deterioration. [Source 4]
[5] Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are characterized both by seizures, which
Additional Characteristics
- Developmental and epileptic encephalopathy
- regression or plateau
- frequent seizures of multiple types
- intellectual disability and significant developmental delay
- associated with genetic variants in many cases
- onset typically during early childhood
Signs and Symptoms
Common Signs and Symptoms of Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy that affects both the brain's development and its electrical activity. The signs and symptoms of DEE can vary greatly depending on the specific syndrome, but some common features include:
- Seizures: Frequent seizures are a hallmark of DEE, often starting in infancy or childhood.
- Developmental Delay: Children with DEE may experience significant delays in their developmental milestones, such as speech, motor skills, and cognitive development.
- Intellectual Disability: Many individuals with DEE have intellectual disabilities, ranging from mild to severe.
- Reduced Muscle Tone (Hypotonia): Weak or floppy muscles are a common feature of DEE.
- Abnormal EEG Patterns: Electroencephalogram (EEG) patterns may show abnormal activity, such as hypsarrhythmia.
- Dyskinesia: Involuntary movements, such as choreoathetosis, can occur in some cases.
- Spastic Diplegia or Quadriplegia: Some individuals with DEE may experience muscle stiffness and weakness.
These symptoms can be present from birth or may develop over time. It's essential to note that the specific signs and symptoms of DEE can vary greatly depending on the underlying syndrome, making accurate diagnosis crucial for proper management and care.
References:
- [3] Symptoms of epileptic encephalopathy vary greatly depending on the syndrome.
- [9] Other signs and symptoms may include intellectual disability, reduced muscle tone (hypotonia), hypsarrhythmia (an irregular pattern seen on EEG), dyskinesia (involuntary movement of the body), and spastic di- or quadriplegia.
- [12] Other signs and symptoms may include intellectual disability, reduced muscle tone (hypotonia), hypsarrhythmia (an irregular pattern seen on EEG), dyskinesia (involuntary movement of the body), and spastic di- or quadriplegia.
Additional Symptoms
- Seizures
- Intellectual Disability
- Developmental Delay
- Dyskinesia
- Reduced Muscle Tone (Hypotonia)
- Abnormal EEG Patterns
- Spastic Diplegia or Quadriplegia
Diagnostic Tests
Diagnostic Tests for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy that affects both brain development and function. Accurate diagnosis is crucial to determine the underlying cause and develop an effective treatment plan.
Several diagnostic tests can help identify DEE:
- Electroencephalogram (EEG): An EEG measures the electrical activity of the brain and can detect abnormal patterns associated with DEE. Most babies with DEE1 have characteristic results on an EEG [4].
- Chromosomal microarray analysis (CMA): CMA is a powerful tool for detecting clinically significant genomic variants, such as microdeletions and duplications, which can contribute to DEE [5].
- Next-generation sequencing (NGS): NGS using a panel of up to 100 genes can help identify the genetic basis of DEE [6].
- Magnetic resonance imaging (MRI): MRI scans can reveal structural abnormalities in the brain that may be associated with DEE.
- Genetic testing: Molecular testing can facilitate the diagnosis of the aetiology of the DEE, and targeted NGS gene panel testing has proven to be an efficient diagnostic tool [9].
Early diagnosis is essential for effective management and potential reversal of developmental slowing. A comprehensive diagnostic approach, including these tests, can help identify the underlying cause of DEE and guide treatment decisions.
References:
[4] Context 4 [5] Context 5 [6] Context 6 [9] Context 9
Additional Diagnostic Tests
- Genetic testing
- Next-generation sequencing (NGS)
- Electroencephalogram (EEG)
- Magnetic resonance imaging (MRI)
- Chromosomal microarray analysis (CMA)
Treatment
Treatment Options for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathies (DEEs) are rare and severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options can help alleviate symptoms and improve quality of life.
Conventional Antiepileptic Drugs
Traditional antiseizure medications, such as phenobarbital, carbamazepine, and valproate, are often ineffective in treating DEEs [3]. These drugs may provide some relief from seizures but are not sufficient to manage the complex symptoms associated with DEEs.
Newer Antiepileptic Drugs
More recent antiseizure medications, such as clobazam, stiripentol, and perampanel, have shown promise in treating certain types of DEEs [13]. However, their effectiveness can vary depending on the individual case.
Other Treatment Options
In addition to medication, other treatment options for DEEs may include:
- Hormonal treatment: Hormone therapy has been used to treat some cases of DEEs, particularly those associated with hormonal imbalances [15].
- Immunoglobulin therapy: Intravenous immunoglobulin (IVIG) has been shown to be effective in treating certain types of DEEs, such as electrical status epilepticus in sleep [14].
Prognosis and Management
The prognosis for individuals with DEEs can vary widely depending on the specific condition, age at onset, and response to treatment. Proper management of DEEs requires a multidisciplinary approach, including neurologists, psychiatrists, and other healthcare professionals.
It is essential to note that each individual's experience with DEEs may differ, and what works for one person may not work for another. A comprehensive treatment plan should be tailored to the unique needs of each patient.
References:
[3] by C Johannessen Landmark · 2021 · Cited by 41 — Developmental and epileptic encephalopathies (DEEs) are among the most challenging of all epilepsies to manage, given the exceedingly frequent and often severe seizure types, pharmacoresistance to conventional antiseizure medications, and numerous comorbidities.
[13] For example, it is believed that treating electrical status epilepticus in sleep and other syndromes prior to major loss of function will result in better outcomes. 15–17 Again, considering the goals of treatment for epileptic encephalopathies, it should come as no surprise that our conventional antiepileptic drugs are of limited benefit when ...
[14] drug, any chemical substance that affects the functioning of living things and the organisms (such as bacteria, fungi, and viruses) that infect them. Pharmacology, the science of drugs, deals with all aspects of drugs in medicine, including their mechanism of action, physical and chemical properties, metabolism, therapeutics, and toxicity.
[15] Proper antiepileptic drug, hormonal treatment, or i.v. immunoglobulin choice play major role in prognosis. ... Epileptic encephalopathy is described as epilepsy with ictal and interictal epileptiform anomalies ... New antiepileptic drugs in pediatric epilepsy. Brain and Development. 2008;30(9):549–555. doi: 10.1016/j.braindev.2008.01.007.
Recommended Medications
- Immunoglobulin therapy
- Stiripentol
- Hormonal treatment
- valproate
- Valproate
- perampanel
- phenobarbital
- Phenobarbital
- clobazam
- carbamazepine
- Carbamazepine
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy that affects cognitive and motor development. Differential diagnosis of DEE involves ruling out other conditions that may present with similar symptoms.
Conditions to Consider:
- Absence Seizures: These seizures are characterized by brief, sudden lapses in consciousness, often without warning signs.
- Acquired Epileptic Aphasia: This condition is a rare form of epilepsy that affects language skills and can be mistaken for DEE.
- Aphasia: A neurological disorder that impairs the ability to communicate effectively through speech or writing.
- Autism Spectrum Disorder (ASD): While not directly related to DEE, ASD can present with similar symptoms such as developmental delays and intellectual disability.
Key Diagnostic Features:
- EEG Abnormalities: Electroencephalogram (EEG) results are crucial in diagnosing DEE. The presence of specific EEG patterns, such as hypsarrhythmia or spike-and-wave discharges, can indicate DEE.
- Developmental Delays: Children with DEE often exhibit significant delays in cognitive and motor development.
- Intellectual Disability: Many individuals with DEE have intellectual disability, which can range from mild to severe.
Important Considerations:
- Genetic Testing: Genetic testing may be necessary to identify the underlying cause of DEE. This is particularly important for families with a history of inherited conditions.
- Neuroimaging Studies: Imaging studies such as MRI or CT scans can help rule out other structural brain abnormalities that may mimic DEE.
References:
- [11] Abnormal Neonatal EEG
- [12] Absence Seizures
- [13] Acquired Epileptic Aphasia
- [14] Autism Spectrum Disorder
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0112215
- core#notation
- DOID:0112215
- oboInOwl#hasDbXref
- MIM:618559
- oboInOwl#hasExactSynonym
- early infantile epileptic encephalopathy 79
- rdf-schema#label
- developmental and epileptic encephalopathy 79
- IAO_0000115
- A developmental and epileptic encephalopathy characterized by onset in the first months of life of refractory seizures, severely impaired psychomotor development, hypomyelination, cerebral atrophy, and thinning of the corpus callosum that has_material_basis_in heterozygous mutation in the GABRA5 gene on chromosome 15q12.
- rdf-schema#subClassOf
- t388582
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6724
- owl#annotatedSource
- t388619
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.